nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—CYP2C18—Ifosfamide—germ cell cancer	0.116	0.176	CbGbCtD
Valproic Acid—SLC16A1—Methotrexate—germ cell cancer	0.0637	0.097	CbGbCtD
Valproic Acid—SLC22A5—Dactinomycin—germ cell cancer	0.0627	0.0955	CbGbCtD
Valproic Acid—CYP2A6—Ifosfamide—germ cell cancer	0.0563	0.0858	CbGbCtD
Valproic Acid—PTGS1—Ifosfamide—germ cell cancer	0.0481	0.0733	CbGbCtD
Valproic Acid—CYP2B6—Ifosfamide—germ cell cancer	0.0367	0.0558	CbGbCtD
Valproic Acid—SLC22A7—Methotrexate—germ cell cancer	0.0313	0.0477	CbGbCtD
Valproic Acid—CYP3A5—Ifosfamide—germ cell cancer	0.0289	0.044	CbGbCtD
Valproic Acid—CYP2C8—Ifosfamide—germ cell cancer	0.0278	0.0423	CbGbCtD
Valproic Acid—CYP2C19—Ifosfamide—germ cell cancer	0.0233	0.0355	CbGbCtD
Valproic Acid—PTGS1—Etoposide—germ cell cancer	0.023	0.035	CbGbCtD
Valproic Acid—CYP2C9—Ifosfamide—germ cell cancer	0.0194	0.0295	CbGbCtD
Valproic Acid—SLC22A8—Methotrexate—germ cell cancer	0.0191	0.0291	CbGbCtD
Valproic Acid—CYP2B6—Cisplatin—germ cell cancer	0.0178	0.0272	CbGbCtD
Valproic Acid—CYP3A5—Etoposide—germ cell cancer	0.0138	0.021	CbGbCtD
Valproic Acid—SLC22A6—Methotrexate—germ cell cancer	0.0133	0.0203	CbGbCtD
Valproic Acid—CYP2C8—Etoposide—germ cell cancer	0.0133	0.0202	CbGbCtD
Valproic Acid—CYP3A4—Ifosfamide—germ cell cancer	0.0113	0.0172	CbGbCtD
Valproic Acid—CYP1A2—Etoposide—germ cell cancer	0.0103	0.0156	CbGbCtD
Valproic Acid—CYP2C9—Cisplatin—germ cell cancer	0.00942	0.0143	CbGbCtD
Valproic Acid—CYP3A4—Vinblastine—germ cell cancer	0.00597	0.0091	CbGbCtD
Valproic Acid—CYP3A4—Etoposide—germ cell cancer	0.00538	0.0082	CbGbCtD
Valproic Acid—SLC22A8—choroid plexus—germ cell cancer	0.00516	0.0442	CbGeAlD
Valproic Acid—OGDH—urine—germ cell cancer	0.00456	0.0391	CbGeAlD
Valproic Acid—CYP2C9—cardial valve—germ cell cancer	0.00416	0.0356	CbGeAlD
Valproic Acid—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.00327	0.0561	CbGpPWpGaD
Valproic Acid—UGT1A10—Metapathway biotransformation—NAT9—germ cell cancer	0.00282	0.0484	CbGpPWpGaD
Valproic Acid—OGDH—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.00251	0.0431	CbGpPWpGaD
Valproic Acid—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00239	0.041	CbGpPWpGaD
Valproic Acid—HDAC2—Teniposide—Etoposide—germ cell cancer	0.0023	1	CbGdCrCtD
Valproic Acid—HDAC2—telencephalic ventricle—germ cell cancer	0.00225	0.0193	CbGeAlD
Valproic Acid—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00222	0.0381	CbGpPWpGaD
Valproic Acid—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00201	0.0344	CbGpPWpGaD
Valproic Acid—SLC22A8—optic choroid—germ cell cancer	0.00198	0.0169	CbGeAlD
Valproic Acid—UGT1A6—Metapathway biotransformation—NAT9—germ cell cancer	0.00175	0.03	CbGpPWpGaD
Valproic Acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00167	0.0287	CbGpPWpGaD
Valproic Acid—SLC22A8—urine—germ cell cancer	0.00138	0.0118	CbGeAlD
Valproic Acid—UGT1A4—Metapathway biotransformation—NAT9—germ cell cancer	0.00135	0.0232	CbGpPWpGaD
Valproic Acid—OGDH—eye—germ cell cancer	0.00131	0.0113	CbGeAlD
Valproic Acid—OGDH—retina—germ cell cancer	0.0013	0.0112	CbGeAlD
Valproic Acid—SLC16A1—Pyruvate metabolism—CRABP1—germ cell cancer	0.00129	0.0221	CbGpPWpGaD
Valproic Acid—ACADSB—trigeminal ganglion—germ cell cancer	0.00121	0.0104	CbGeAlD
Valproic Acid—OGDH—telencephalon—germ cell cancer	0.0012	0.0103	CbGeAlD
Valproic Acid—HDAC9—eye—germ cell cancer	0.00116	0.00993	CbGeAlD
Valproic Acid—CYP2C19—urine—germ cell cancer	0.00116	0.00991	CbGeAlD
Valproic Acid—OGDH—decidua—germ cell cancer	0.00114	0.00973	CbGeAlD
Valproic Acid—UGT1A3—Metapathway biotransformation—NAT9—germ cell cancer	0.00112	0.0193	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00111	0.019	CbGpPWpGaD
Valproic Acid—ALDH5A1—trigeminal ganglion—germ cell cancer	0.00107	0.00915	CbGeAlD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00107	0.0183	CbGpPWpGaD
Valproic Acid—HDAC9—telencephalon—germ cell cancer	0.00106	0.00905	CbGeAlD
Valproic Acid—UGT1A10—endocrine gland—germ cell cancer	0.00103	0.00882	CbGeAlD
Valproic Acid—HDAC9—decidua—germ cell cancer	0.001	0.00858	CbGeAlD
Valproic Acid—OGDH—gonad—germ cell cancer	0.001	0.00857	CbGeAlD
Valproic Acid—OGDH—uterus—germ cell cancer	0.000993	0.00852	CbGeAlD
Valproic Acid—CYP2C18—Metapathway biotransformation—NAT9—germ cell cancer	0.000982	0.0168	CbGpPWpGaD
Valproic Acid—OGDH—pituitary gland—germ cell cancer	0.000976	0.00836	CbGeAlD
Valproic Acid—OGDH—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.000974	0.0167	CbGpPWpGaD
Valproic Acid—UGT1A6—endocrine gland—germ cell cancer	0.000956	0.0082	CbGeAlD
Valproic Acid—UGT2B7—Metapathway biotransformation—NAT9—germ cell cancer	0.000955	0.0164	CbGpPWpGaD
Valproic Acid—CYP1A2—urine—germ cell cancer	0.000945	0.0081	CbGeAlD
Valproic Acid—ALDH5A1—brainstem—germ cell cancer	0.000944	0.00809	CbGeAlD
Valproic Acid—OGDH—medulla oblongata—germ cell cancer	0.000941	0.00807	CbGeAlD
Valproic Acid—UGT1A6—testis—germ cell cancer	0.000912	0.00782	CbGeAlD
Valproic Acid—ACADSB—decidua—germ cell cancer	0.000902	0.00773	CbGeAlD
Valproic Acid—CYP2C9—urine—germ cell cancer	0.000897	0.00769	CbGeAlD
Valproic Acid—HDAC9—uterus—germ cell cancer	0.000876	0.00751	CbGeAlD
Valproic Acid—OGDH—adrenal gland—germ cell cancer	0.000872	0.00747	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—SALL4—germ cell cancer	0.000855	0.0147	CbGpPWpGaD
Valproic Acid—OGDH—bone marrow—germ cell cancer	0.000843	0.00723	CbGeAlD
Valproic Acid—OGDH—spinal cord—germ cell cancer	0.00084	0.0072	CbGeAlD
Valproic Acid—ALDH5A1—telencephalon—germ cell cancer	0.000838	0.00718	CbGeAlD
Valproic Acid—UGT1A8—endocrine gland—germ cell cancer	0.000813	0.00697	CbGeAlD
Valproic Acid—OGDH—female gonad—germ cell cancer	0.000813	0.00697	CbGeAlD
Valproic Acid—ABAT—brainstem—germ cell cancer	0.000808	0.00692	CbGeAlD
Valproic Acid—UGT1A8—head—germ cell cancer	0.000803	0.00688	CbGeAlD
Valproic Acid—HDAC2—neck—germ cell cancer	0.000796	0.00683	CbGeAlD
Valproic Acid—ALDH5A1—decidua—germ cell cancer	0.000794	0.00681	CbGeAlD
Valproic Acid—ACADSB—uterus—germ cell cancer	0.000789	0.00676	CbGeAlD
Valproic Acid—ABAT—eye—germ cell cancer	0.000786	0.00674	CbGeAlD
Valproic Acid—ABAT—retina—germ cell cancer	0.000779	0.00668	CbGeAlD
Valproic Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.000778	0.0134	CbGpPWpGaD
Valproic Acid—UGT1A9—Metapathway biotransformation—NAT9—germ cell cancer	0.000776	0.0133	CbGpPWpGaD
Valproic Acid—ACADSB—pituitary gland—germ cell cancer	0.000775	0.00664	CbGeAlD
Valproic Acid—HDAC9—adrenal gland—germ cell cancer	0.000768	0.00659	CbGeAlD
Valproic Acid—HDAC9—midbrain—germ cell cancer	0.000759	0.0065	CbGeAlD
Valproic Acid—OGDH—endocrine gland—germ cell cancer	0.000756	0.00648	CbGeAlD
Valproic Acid—ACADSB—medulla oblongata—germ cell cancer	0.000748	0.00641	CbGeAlD
Valproic Acid—OGDH—head—germ cell cancer	0.000746	0.0064	CbGeAlD
Valproic Acid—HDAC9—bone marrow—germ cell cancer	0.000743	0.00637	CbGeAlD
Valproic Acid—UGT1A3—endocrine gland—germ cell cancer	0.000725	0.00621	CbGeAlD
Valproic Acid—OGDH—testis—germ cell cancer	0.000721	0.00618	CbGeAlD
Valproic Acid—ABAT—telencephalon—germ cell cancer	0.000717	0.00615	CbGeAlD
Valproic Acid—HDAC9—female gonad—germ cell cancer	0.000716	0.00614	CbGeAlD
Valproic Acid—ALDH5A1—gonad—germ cell cancer	0.000699	0.00599	CbGeAlD
Valproic Acid—ACADSB—adrenal gland—germ cell cancer	0.000692	0.00593	CbGeAlD
Valproic Acid—HDAC2—trigeminal ganglion—germ cell cancer	0.000688	0.00589	CbGeAlD
Valproic Acid—CYP3A4—urine—germ cell cancer	0.000684	0.00586	CbGeAlD
Valproic Acid—ACADSB—midbrain—germ cell cancer	0.000684	0.00586	CbGeAlD
Valproic Acid—UGT2B15—endocrine gland—germ cell cancer	0.000681	0.00584	CbGeAlD
Valproic Acid—ACADSB—bone marrow—germ cell cancer	0.00067	0.00574	CbGeAlD
Valproic Acid—ACADSB—spinal cord—germ cell cancer	0.000667	0.00572	CbGeAlD
Valproic Acid—OGDH—cerebellum—germ cell cancer	0.000666	0.00571	CbGeAlD
Valproic Acid—HDAC2—embryo—germ cell cancer	0.000664	0.00569	CbGeAlD
Valproic Acid—ALDH5A1—medulla oblongata—germ cell cancer	0.000658	0.00564	CbGeAlD
Valproic Acid—HDAC9—head—germ cell cancer	0.000658	0.00564	CbGeAlD
Valproic Acid—ACADSB—female gonad—germ cell cancer	0.000646	0.00553	CbGeAlD
Valproic Acid—HDAC9—testis—germ cell cancer	0.000635	0.00545	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—KLF4—germ cell cancer	0.000622	0.0107	CbGpPWpGaD
Valproic Acid—UGT1A4—endocrine gland—germ cell cancer	0.000616	0.00528	CbGeAlD
Valproic Acid—ALDH5A1—adrenal gland—germ cell cancer	0.00061	0.00522	CbGeAlD
Valproic Acid—HDAC2—brainstem—germ cell cancer	0.000609	0.00522	CbGeAlD
Valproic Acid—ALDH5A1—midbrain—germ cell cancer	0.000602	0.00516	CbGeAlD
Valproic Acid—ACADSB—endocrine gland—germ cell cancer	0.0006	0.00515	CbGeAlD
Valproic Acid—ABAT—gonad—germ cell cancer	0.000598	0.00513	CbGeAlD
Valproic Acid—HDAC2—eye—germ cell cancer	0.000592	0.00508	CbGeAlD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000592	0.0102	CbGpPWpGaD
Valproic Acid—ALDH5A1—bone marrow—germ cell cancer	0.00059	0.00505	CbGeAlD
Valproic Acid—ALDH5A1—spinal cord—germ cell cancer	0.000587	0.00503	CbGeAlD
Valproic Acid—HDAC2—retina—germ cell cancer	0.000587	0.00503	CbGeAlD
Valproic Acid—HDAC9—cerebellum—germ cell cancer	0.000587	0.00503	CbGeAlD
Valproic Acid—HDAC2—Epigenetic regulation of gene expression—DNMT3L—germ cell cancer	0.000585	0.01	CbGpPWpGaD
Valproic Acid—ABAT—pituitary gland—germ cell cancer	0.000584	0.005	CbGeAlD
Valproic Acid—ACADSB—testis—germ cell cancer	0.000573	0.00491	CbGeAlD
Valproic Acid—ALDH5A1—female gonad—germ cell cancer	0.000568	0.00487	CbGeAlD
Valproic Acid—ABAT—medulla oblongata—germ cell cancer	0.000563	0.00483	CbGeAlD
Valproic Acid—PTGS1—ganglion—germ cell cancer	0.000558	0.00478	CbGeAlD
Valproic Acid—UGT1A6—NRF2 pathway—SLC2A3—germ cell cancer	0.000549	0.00943	CbGpPWpGaD
Valproic Acid—OGDH—brain—germ cell cancer	0.000541	0.00463	CbGeAlD
Valproic Acid—HDAC2—telencephalon—germ cell cancer	0.00054	0.00463	CbGeAlD
Valproic Acid—ACADSB—cerebellum—germ cell cancer	0.000529	0.00453	CbGeAlD
Valproic Acid—ALDH5A1—endocrine gland—germ cell cancer	0.000529	0.00453	CbGeAlD
Valproic Acid—SLC16A1—eye—germ cell cancer	0.000526	0.00451	CbGeAlD
Valproic Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000524	0.009	CbGpPWpGaD
Valproic Acid—OGDH—lymph node—germ cell cancer	0.000522	0.00448	CbGeAlD
Valproic Acid—ALDH5A1—head—germ cell cancer	0.000522	0.00447	CbGeAlD
Valproic Acid—SLC16A1—retina—germ cell cancer	0.000522	0.00447	CbGeAlD
Valproic Acid—ABAT—adrenal gland—germ cell cancer	0.000521	0.00447	CbGeAlD
Valproic Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000517	0.00887	CbGpPWpGaD
Valproic Acid—UGT1A9—endocrine gland—germ cell cancer	0.000516	0.00443	CbGeAlD
Valproic Acid—HDAC2—skin of body—germ cell cancer	0.000515	0.00442	CbGeAlD
Valproic Acid—ABAT—midbrain—germ cell cancer	0.000515	0.00441	CbGeAlD
Valproic Acid—HDAC2—decidua—germ cell cancer	0.000512	0.00439	CbGeAlD
Valproic Acid—ALDH5A1—testis—germ cell cancer	0.000504	0.00432	CbGeAlD
Valproic Acid—ABAT—spinal cord—germ cell cancer	0.000502	0.00431	CbGeAlD
Valproic Acid—ABAT—female gonad—germ cell cancer	0.000486	0.00417	CbGeAlD
Valproic Acid—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000485	0.00833	CbGpPWpGaD
Valproic Acid—CYP2B6—Metapathway biotransformation—NAT9—germ cell cancer	0.000483	0.00828	CbGpPWpGaD
Valproic Acid—PTGS1—endothelium—germ cell cancer	0.000481	0.00412	CbGeAlD
Valproic Acid—SLC16A1—telencephalon—germ cell cancer	0.00048	0.00411	CbGeAlD
Valproic Acid—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000478	0.0082	CbGpPWpGaD
Valproic Acid—HDAC9—brain—germ cell cancer	0.000477	0.00409	CbGeAlD
Valproic Acid—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000472	0.0081	CbGpPWpGaD
Valproic Acid—ALDH5A1—cerebellum—germ cell cancer	0.000466	0.00399	CbGeAlD
Valproic Acid—SLC22A8—trigeminal ganglion—germ cell cancer	0.000462	0.00396	CbGeAlD
Valproic Acid—HDAC9—lymph node—germ cell cancer	0.000461	0.00395	CbGeAlD
Valproic Acid—SLC16A1—decidua—germ cell cancer	0.000455	0.0039	CbGeAlD
Valproic Acid—ABAT—endocrine gland—germ cell cancer	0.000452	0.00388	CbGeAlD
Valproic Acid—CYP2C18—endocrine gland—germ cell cancer	0.000451	0.00387	CbGeAlD
Valproic Acid—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000451	0.00774	CbGpPWpGaD
Valproic Acid—HDAC2—gonad—germ cell cancer	0.000451	0.00386	CbGeAlD
Valproic Acid—HDAC2—uterus—germ cell cancer	0.000448	0.00384	CbGeAlD
Valproic Acid—ABAT—head—germ cell cancer	0.000446	0.00383	CbGeAlD
Valproic Acid—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000444	0.00762	CbGpPWpGaD
Valproic Acid—PTGS1—blood vessel—germ cell cancer	0.000444	0.0038	CbGeAlD
Valproic Acid—HDAC2—pituitary gland—germ cell cancer	0.00044	0.00377	CbGeAlD
Valproic Acid—ABAT—testis—germ cell cancer	0.000431	0.0037	CbGeAlD
Valproic Acid—ACADSB—brain—germ cell cancer	0.00043	0.00368	CbGeAlD
Valproic Acid—HDAC2—medulla oblongata—germ cell cancer	0.000424	0.00364	CbGeAlD
Valproic Acid—UGT1A4—NRF2 pathway—SLC2A3—germ cell cancer	0.000424	0.00728	CbGpPWpGaD
Valproic Acid—UGT2B7—endocrine gland—germ cell cancer	0.000416	0.00357	CbGeAlD
Valproic Acid—ACADSB—lymph node—germ cell cancer	0.000415	0.00356	CbGeAlD
Valproic Acid—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000409	0.00701	CbGpPWpGaD
Valproic Acid—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000408	0.007	CbGpPWpGaD
Valproic Acid—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000402	0.00689	CbGpPWpGaD
Valproic Acid—SLC16A1—gonad—germ cell cancer	0.000401	0.00343	CbGeAlD
Valproic Acid—ABAT—cerebellum—germ cell cancer	0.000398	0.00341	CbGeAlD
Valproic Acid—SLC22A8—eye—germ cell cancer	0.000398	0.00341	CbGeAlD
Valproic Acid—SLC16A1—uterus—germ cell cancer	0.000398	0.00341	CbGeAlD
Valproic Acid—UGT2B7—testis—germ cell cancer	0.000397	0.0034	CbGeAlD
Valproic Acid—SLC22A7—endocrine gland—germ cell cancer	0.000396	0.00339	CbGeAlD
Valproic Acid—HDAC2—adrenal gland—germ cell cancer	0.000393	0.00337	CbGeAlD
Valproic Acid—SLC16A1—pituitary gland—germ cell cancer	0.000391	0.00335	CbGeAlD
Valproic Acid—HDAC2—midbrain—germ cell cancer	0.000388	0.00332	CbGeAlD
Valproic Acid—HDAC2—bone marrow—germ cell cancer	0.00038	0.00326	CbGeAlD
Valproic Acid—ALDH5A1—brain—germ cell cancer	0.000378	0.00324	CbGeAlD
Valproic Acid—SLC22A7—testis—germ cell cancer	0.000378	0.00324	CbGeAlD
Valproic Acid—SLC16A1—medulla oblongata—germ cell cancer	0.000377	0.00323	CbGeAlD
Valproic Acid—HDAC9—Neural Crest Differentiation—FGFR3—germ cell cancer	0.000376	0.00645	CbGpPWpGaD
Valproic Acid—HDAC2—female gonad—germ cell cancer	0.000366	0.00314	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—germ cell cancer	0.000365	0.00313	CbGeAlD
Valproic Acid—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	0.000365	0.00626	CbGpPWpGaD
Valproic Acid—UGT1A3—NRF2 pathway—SLC2A3—germ cell cancer	0.000353	0.00605	CbGpPWpGaD
Valproic Acid—HDAC9—NOTCH1 Intracellular Domain Regulates Transcription—MYC—germ cell cancer	0.00035	0.00601	CbGpPWpGaD
Valproic Acid—SLC22A5—trigeminal ganglion—germ cell cancer	0.000349	0.00299	CbGeAlD
Valproic Acid—SLC16A1—adrenal gland—germ cell cancer	0.000349	0.00299	CbGeAlD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000349	0.00599	CbGpPWpGaD
Valproic Acid—SLC16A1—midbrain—germ cell cancer	0.000345	0.00295	CbGeAlD
Valproic Acid—HDAC2—endocrine gland—germ cell cancer	0.000341	0.00292	CbGeAlD
Valproic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00034	0.00584	CbGpPWpGaD
Valproic Acid—HDAC2—head—germ cell cancer	0.000336	0.00288	CbGeAlD
Valproic Acid—SLC16A1—spinal cord—germ cell cancer	0.000336	0.00288	CbGeAlD
Valproic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000335	0.00575	CbGpPWpGaD
Valproic Acid—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000333	0.00571	CbGpPWpGaD
Valproic Acid—SLC16A1—female gonad—germ cell cancer	0.000325	0.00279	CbGeAlD
Valproic Acid—HDAC2—testis—germ cell cancer	0.000325	0.00278	CbGeAlD
Valproic Acid—ABAT—brain—germ cell cancer	0.000324	0.00277	CbGeAlD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	0.000321	0.00552	CbGpPWpGaD
Valproic Acid—ABAT—lymph node—germ cell cancer	0.000313	0.00268	CbGeAlD
Valproic Acid—HDAC9—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—MYC—germ cell cancer	0.000304	0.00522	CbGpPWpGaD
Valproic Acid—SLC16A1—endocrine gland—germ cell cancer	0.000303	0.00259	CbGeAlD
Valproic Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.000302	0.00518	CbGpPWpGaD
Valproic Acid—HDAC2—cerebellum—germ cell cancer	0.0003	0.00257	CbGeAlD
Valproic Acid—UGT2B7—NRF2 pathway—SLC2A3—germ cell cancer	0.0003	0.00515	CbGpPWpGaD
Valproic Acid—SLC16A1—head—germ cell cancer	0.000299	0.00256	CbGeAlD
Valproic Acid—SLC22A5—retina—germ cell cancer	0.000298	0.00255	CbGeAlD
Valproic Acid—SLC16A1—testis—germ cell cancer	0.000289	0.00247	CbGeAlD
Valproic Acid—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000284	0.00488	CbGpPWpGaD
Valproic Acid—SLC22A7—brain—germ cell cancer	0.000283	0.00243	CbGeAlD
Valproic Acid—SLC22A6—brain—germ cell cancer	0.000273	0.00234	CbGeAlD
Valproic Acid—SLC16A1—cerebellum—germ cell cancer	0.000267	0.00229	CbGeAlD
Valproic Acid—CYP2A6—cerebellum—germ cell cancer	0.000263	0.00225	CbGeAlD
Valproic Acid—SLC22A5—skin of body—germ cell cancer	0.000262	0.00224	CbGeAlD
Valproic Acid—HDAC9—FBXW7 Mutants and NOTCH1 in Cancer—MYC—germ cell cancer	0.000252	0.00432	CbGpPWpGaD
Valproic Acid—HDAC2—brain—germ cell cancer	0.000244	0.00209	CbGeAlD
Valproic Acid—UGT1A9—NRF2 pathway—SLC2A3—germ cell cancer	0.000244	0.00418	CbGpPWpGaD
Valproic Acid—SLC16A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000238	0.00409	CbGpPWpGaD
Valproic Acid—HDAC2—NoRC negatively regulates rRNA expression—H2AFZ—germ cell cancer	0.000236	0.00406	CbGpPWpGaD
Valproic Acid—HDAC2—lymph node—germ cell cancer	0.000235	0.00202	CbGeAlD
Valproic Acid—SLC16A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000235	0.00403	CbGpPWpGaD
Valproic Acid—HDAC2—Negative epigenetic regulation of rRNA expression—H2AFZ—germ cell cancer	0.000231	0.00396	CbGpPWpGaD
Valproic Acid—HDAC2—RNA Polymerase I Promoter Clearance—H2AFZ—germ cell cancer	0.000231	0.00396	CbGpPWpGaD
Valproic Acid—HDAC2—RNA Polymerase I Transcription—H2AFZ—germ cell cancer	0.000227	0.0039	CbGpPWpGaD
Valproic Acid—CYP2B6—skin of body—germ cell cancer	0.000227	0.00195	CbGeAlD
Valproic Acid—SLC22A8—head—germ cell cancer	0.000226	0.00194	CbGeAlD
Valproic Acid—SLC22A5—pituitary gland—germ cell cancer	0.000223	0.00191	CbGeAlD
Valproic Acid—SLC22A7—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000221	0.00378	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000219	0.00376	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—KITLG—germ cell cancer	0.000217	0.00373	CbGpPWpGaD
Valproic Acid—SLC22A7—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000217	0.00373	CbGpPWpGaD
Valproic Acid—SLC16A1—brain—germ cell cancer	0.000217	0.00186	CbGeAlD
Valproic Acid—CYP2C8—pituitary gland—germ cell cancer	0.000216	0.00185	CbGeAlD
Valproic Acid—SLC22A5—medulla oblongata—germ cell cancer	0.000215	0.00185	CbGeAlD
Valproic Acid—PTGS1—telencephalon—germ cell cancer	0.000215	0.00184	CbGeAlD
Valproic Acid—ACADSB—Metabolism—SLC2A3—germ cell cancer	0.000215	0.00369	CbGpPWpGaD
Valproic Acid—CYP2A6—brain—germ cell cancer	0.000213	0.00183	CbGeAlD
Valproic Acid—ACADSB—Metabolism—SLC22A3—germ cell cancer	0.000212	0.00364	CbGpPWpGaD
Valproic Acid—SLC16A1—lymph node—germ cell cancer	0.000209	0.00179	CbGeAlD
Valproic Acid—Erythema multiforme—Etoposide—germ cell cancer	0.000208	0.00125	CcSEcCtD
Valproic Acid—Paraesthesia—Bleomycin—germ cell cancer	0.000208	0.00125	CcSEcCtD
Valproic Acid—Dyspnoea—Bleomycin—germ cell cancer	0.000207	0.00124	CcSEcCtD
Valproic Acid—Arthralgia—Ifosfamide—germ cell cancer	0.000207	0.00124	CcSEcCtD
Valproic Acid—Myalgia—Ifosfamide—germ cell cancer	0.000207	0.00124	CcSEcCtD
Valproic Acid—Chest pain—Ifosfamide—germ cell cancer	0.000207	0.00124	CcSEcCtD
Valproic Acid—Flatulence—Cisplatin—germ cell cancer	0.000206	0.00124	CcSEcCtD
Valproic Acid—Anorexia—Dactinomycin—germ cell cancer	0.000206	0.00124	CcSEcCtD
Valproic Acid—Eye disorder—Etoposide—germ cell cancer	0.000206	0.00124	CcSEcCtD
Valproic Acid—PTGS1—skin of body—germ cell cancer	0.000205	0.00176	CbGeAlD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000205	0.00124	CcSEcCtD
Valproic Acid—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000205	0.00352	CbGpPWpGaD
Valproic Acid—HDAC2—Epigenetic regulation of gene expression—H2AFZ—germ cell cancer	0.000205	0.00351	CbGpPWpGaD
Valproic Acid—Discomfort—Ifosfamide—germ cell cancer	0.000204	0.00123	CcSEcCtD
Valproic Acid—Hypersensitivity—Vinblastine—germ cell cancer	0.000202	0.00122	CcSEcCtD
Valproic Acid—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000202	0.00346	CbGpPWpGaD
Valproic Acid—Decreased appetite—Bleomycin—germ cell cancer	0.000202	0.00121	CcSEcCtD
Valproic Acid—Muscle spasms—Cisplatin—germ cell cancer	0.000201	0.00121	CcSEcCtD
Valproic Acid—Angiopathy—Etoposide—germ cell cancer	0.0002	0.0012	CcSEcCtD
Valproic Acid—Confusional state—Ifosfamide—germ cell cancer	0.0002	0.0012	CcSEcCtD
Valproic Acid—SLC22A5—adrenal gland—germ cell cancer	0.000199	0.00171	CbGeAlD
Valproic Acid—Immune system disorder—Etoposide—germ cell cancer	0.000199	0.0012	CcSEcCtD
Valproic Acid—CYP2B6—gonad—germ cell cancer	0.000199	0.0017	CbGeAlD
Valproic Acid—Mediastinal disorder—Etoposide—germ cell cancer	0.000199	0.0012	CcSEcCtD
Valproic Acid—Pain—Bleomycin—germ cell cancer	0.000198	0.00119	CcSEcCtD
Valproic Acid—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000198	0.00119	CcSEcCtD
Valproic Acid—Oedema—Ifosfamide—germ cell cancer	0.000198	0.00119	CcSEcCtD
Valproic Acid—Chills—Etoposide—germ cell cancer	0.000198	0.00119	CcSEcCtD
Valproic Acid—Vision blurred—Cisplatin—germ cell cancer	0.000197	0.00119	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000197	0.00119	CcSEcCtD
Valproic Acid—Asthenia—Vinblastine—germ cell cancer	0.000197	0.00119	CcSEcCtD
Valproic Acid—Infection—Ifosfamide—germ cell cancer	0.000197	0.00119	CcSEcCtD
Valproic Acid—SLC22A5—midbrain—germ cell cancer	0.000197	0.00169	CbGeAlD
Valproic Acid—Tremor—Cisplatin—germ cell cancer	0.000196	0.00118	CcSEcCtD
Valproic Acid—Alopecia—Etoposide—germ cell cancer	0.000195	0.00117	CcSEcCtD
Valproic Acid—Lethargy—Methotrexate—germ cell cancer	0.000195	0.00117	CcSEcCtD
Valproic Acid—Nervous system disorder—Ifosfamide—germ cell cancer	0.000194	0.00117	CcSEcCtD
Valproic Acid—Ill-defined disorder—Cisplatin—germ cell cancer	0.000194	0.00117	CcSEcCtD
Valproic Acid—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000194	0.00117	CcSEcCtD
Valproic Acid—Anaemia—Cisplatin—germ cell cancer	0.000194	0.00116	CcSEcCtD
Valproic Acid—Skin disorder—Ifosfamide—germ cell cancer	0.000193	0.00116	CcSEcCtD
Valproic Acid—SLC22A5—spinal cord—germ cell cancer	0.000192	0.00165	CbGeAlD
Valproic Acid—CYP2C19—endocrine gland—germ cell cancer	0.000192	0.00164	CbGeAlD
Valproic Acid—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000192	0.00115	CcSEcCtD
Valproic Acid—Feeling abnormal—Bleomycin—germ cell cancer	0.000191	0.00115	CcSEcCtD
Valproic Acid—Osteoarthritis—Methotrexate—germ cell cancer	0.000191	0.00115	CcSEcCtD
Valproic Acid—HDAC9—Neural Crest Differentiation—MYC—germ cell cancer	0.00019	0.00326	CbGpPWpGaD
Valproic Acid—Anorexia—Ifosfamide—germ cell cancer	0.000189	0.00114	CcSEcCtD
Valproic Acid—Malaise—Cisplatin—germ cell cancer	0.000189	0.00114	CcSEcCtD
Valproic Acid—Decreased appetite—Dactinomycin—germ cell cancer	0.000188	0.00113	CcSEcCtD
Valproic Acid—Diarrhoea—Vinblastine—germ cell cancer	0.000188	0.00113	CcSEcCtD
Valproic Acid—Dysgeusia—Etoposide—germ cell cancer	0.000188	0.00113	CcSEcCtD
Valproic Acid—CYP2A6—NRF2 pathway—SLC2A3—germ cell cancer	0.000188	0.00322	CbGpPWpGaD
Valproic Acid—Leukopenia—Cisplatin—germ cell cancer	0.000187	0.00113	CcSEcCtD
Valproic Acid—Fatigue—Dactinomycin—germ cell cancer	0.000186	0.00112	CcSEcCtD
Valproic Acid—SLC22A5—female gonad—germ cell cancer	0.000186	0.00159	CbGeAlD
Valproic Acid—Back pain—Etoposide—germ cell cancer	0.000186	0.00112	CcSEcCtD
Valproic Acid—SLC22A8—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000185	0.00318	CbGpPWpGaD
Valproic Acid—Hypotension—Ifosfamide—germ cell cancer	0.000185	0.00111	CcSEcCtD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000185	0.00318	CbGpPWpGaD
Valproic Acid—Pain—Dactinomycin—germ cell cancer	0.000185	0.00111	CcSEcCtD
Valproic Acid—Muscle spasms—Etoposide—germ cell cancer	0.000184	0.00111	CcSEcCtD
Valproic Acid—Urticaria—Bleomycin—germ cell cancer	0.000184	0.00111	CcSEcCtD
Valproic Acid—Body temperature increased—Bleomycin—germ cell cancer	0.000183	0.0011	CcSEcCtD
Valproic Acid—OGDH—Metabolism—SLC2A3—germ cell cancer	0.000183	0.00314	CbGpPWpGaD
Valproic Acid—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000183	0.00313	CbGpPWpGaD
Valproic Acid—Dizziness—Vinblastine—germ cell cancer	0.000182	0.00109	CcSEcCtD
Valproic Acid—HDAC2—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—H2AFZ—germ cell cancer	0.000181	0.00311	CbGpPWpGaD
Valproic Acid—Mood swings—Methotrexate—germ cell cancer	0.000181	0.00109	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000181	0.00109	CcSEcCtD
Valproic Acid—OGDH—Metabolism—SLC22A3—germ cell cancer	0.00018	0.00309	CbGpPWpGaD
Valproic Acid—Ataxia—Methotrexate—germ cell cancer	0.000179	0.00108	CcSEcCtD
Valproic Acid—HDAC9—Signaling by NOTCH—MYC—germ cell cancer	0.000179	0.00306	CbGpPWpGaD
Valproic Acid—PTGS1—uterus—germ cell cancer	0.000178	0.00153	CbGeAlD
Valproic Acid—Myalgia—Cisplatin—germ cell cancer	0.000178	0.00107	CcSEcCtD
Valproic Acid—Feeling abnormal—Dactinomycin—germ cell cancer	0.000178	0.00107	CcSEcCtD
Valproic Acid—Paraesthesia—Ifosfamide—germ cell cancer	0.000178	0.00107	CcSEcCtD
Valproic Acid—Ill-defined disorder—Etoposide—germ cell cancer	0.000178	0.00107	CcSEcCtD
Valproic Acid—Anxiety—Cisplatin—germ cell cancer	0.000178	0.00107	CcSEcCtD
Valproic Acid—Anaemia—Etoposide—germ cell cancer	0.000177	0.00107	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000177	0.00107	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000177	0.00106	CcSEcCtD
Valproic Acid—Dyspnoea—Ifosfamide—germ cell cancer	0.000177	0.00106	CcSEcCtD
Valproic Acid—Somnolence—Ifosfamide—germ cell cancer	0.000176	0.00106	CcSEcCtD
Valproic Acid—Discomfort—Cisplatin—germ cell cancer	0.000176	0.00106	CcSEcCtD
Valproic Acid—PTGS1—pituitary gland—germ cell cancer	0.000175	0.0015	CbGeAlD
Valproic Acid—Vomiting—Vinblastine—germ cell cancer	0.000175	0.00105	CcSEcCtD
Valproic Acid—CYP2B6—adrenal gland—germ cell cancer	0.000173	0.00148	CbGeAlD
Valproic Acid—Malaise—Etoposide—germ cell cancer	0.000173	0.00104	CcSEcCtD
Valproic Acid—ACADSB—Metabolism—CRABP1—germ cell cancer	0.000173	0.00296	CbGpPWpGaD
Valproic Acid—Breast disorder—Methotrexate—germ cell cancer	0.000172	0.00104	CcSEcCtD
Valproic Acid—Vertigo—Etoposide—germ cell cancer	0.000172	0.00104	CcSEcCtD
Valproic Acid—Decreased appetite—Ifosfamide—germ cell cancer	0.000172	0.00104	CcSEcCtD
Valproic Acid—Headache—Vinblastine—germ cell cancer	0.000172	0.00104	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000172	0.00103	CcSEcCtD
Valproic Acid—Leukopenia—Etoposide—germ cell cancer	0.000172	0.00103	CcSEcCtD
Valproic Acid—UGT1A9—PPAR Alpha Pathway—MYC—germ cell cancer	0.000172	0.00295	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000171	0.00294	CbGpPWpGaD
Valproic Acid—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000171	0.00103	CcSEcCtD
Valproic Acid—Abdominal pain—Dactinomycin—germ cell cancer	0.000171	0.00103	CcSEcCtD
Valproic Acid—Body temperature increased—Dactinomycin—germ cell cancer	0.000171	0.00103	CcSEcCtD
Valproic Acid—Fatigue—Ifosfamide—germ cell cancer	0.000171	0.00103	CcSEcCtD
Valproic Acid—Anaphylactic shock—Cisplatin—germ cell cancer	0.000171	0.00103	CcSEcCtD
Valproic Acid—Oedema—Cisplatin—germ cell cancer	0.000171	0.00103	CcSEcCtD
Valproic Acid—Hypersensitivity—Bleomycin—germ cell cancer	0.000171	0.00103	CcSEcCtD
Valproic Acid—Infection—Cisplatin—germ cell cancer	0.00017	0.00102	CcSEcCtD
Valproic Acid—Pain—Ifosfamide—germ cell cancer	0.000169	0.00102	CcSEcCtD
Valproic Acid—Constipation—Ifosfamide—germ cell cancer	0.000169	0.00102	CcSEcCtD
Valproic Acid—Nervous system disorder—Cisplatin—germ cell cancer	0.000168	0.00101	CcSEcCtD
Valproic Acid—CYP2C8—endocrine gland—germ cell cancer	0.000167	0.00144	CbGeAlD
Valproic Acid—Cough—Etoposide—germ cell cancer	0.000167	0.00101	CcSEcCtD
Valproic Acid—Thrombocytopenia—Cisplatin—germ cell cancer	0.000167	0.00101	CcSEcCtD
Valproic Acid—SLC22A7—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000167	0.00287	CbGpPWpGaD
Valproic Acid—Tachycardia—Cisplatin—germ cell cancer	0.000167	0.001	CcSEcCtD
Valproic Acid—Asthenia—Bleomycin—germ cell cancer	0.000166	0.001	CcSEcCtD
Valproic Acid—Skin disorder—Cisplatin—germ cell cancer	0.000166	0.000999	CcSEcCtD
Valproic Acid—Hypertension—Etoposide—germ cell cancer	0.000166	0.000997	CcSEcCtD
Valproic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000165	0.00284	CbGpPWpGaD
Valproic Acid—Hyperhidrosis—Cisplatin—germ cell cancer	0.000165	0.000994	CcSEcCtD
Valproic Acid—SLC22A5—testis—germ cell cancer	0.000165	0.00141	CbGeAlD
Valproic Acid—Pruritus—Bleomycin—germ cell cancer	0.000164	0.000988	CcSEcCtD
Valproic Acid—SLC22A8—brain—germ cell cancer	0.000164	0.0014	CbGeAlD
Valproic Acid—Feeling abnormal—Ifosfamide—germ cell cancer	0.000163	0.000983	CcSEcCtD
Valproic Acid—Chest pain—Etoposide—germ cell cancer	0.000163	0.000983	CcSEcCtD
Valproic Acid—Eosinophilia—Methotrexate—germ cell cancer	0.000163	0.000983	CcSEcCtD
Valproic Acid—Nausea—Vinblastine—germ cell cancer	0.000163	0.000982	CcSEcCtD
Valproic Acid—Anorexia—Cisplatin—germ cell cancer	0.000163	0.00098	CcSEcCtD
Valproic Acid—HDAC2—Neural Crest Differentiation—FGFR3—germ cell cancer	0.000163	0.0028	CbGpPWpGaD
Valproic Acid—CYP3A5—female gonad—germ cell cancer	0.000162	0.00139	CbGeAlD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000162	0.000976	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000162	0.000975	CcSEcCtD
Valproic Acid—Pancreatitis—Methotrexate—germ cell cancer	0.000162	0.000973	CcSEcCtD
Valproic Acid—Discomfort—Etoposide—germ cell cancer	0.000161	0.000971	CcSEcCtD
Valproic Acid—Hypotension—Cisplatin—germ cell cancer	0.00016	0.000961	CcSEcCtD
Valproic Acid—CYP2C8—testis—germ cell cancer	0.00016	0.00137	CbGeAlD
Valproic Acid—Hypersensitivity—Dactinomycin—germ cell cancer	0.000159	0.000959	CcSEcCtD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000159	0.00273	CbGpPWpGaD
Valproic Acid—Abdominal discomfort—Methotrexate—germ cell cancer	0.000158	0.000951	CcSEcCtD
Valproic Acid—Confusional state—Etoposide—germ cell cancer	0.000158	0.00095	CcSEcCtD
Valproic Acid—Urticaria—Ifosfamide—germ cell cancer	0.000157	0.000948	CcSEcCtD
Valproic Acid—Abdominal pain—Ifosfamide—germ cell cancer	0.000157	0.000943	CcSEcCtD
Valproic Acid—Body temperature increased—Ifosfamide—germ cell cancer	0.000157	0.000943	CcSEcCtD
Valproic Acid—CYP1A2—endocrine gland—germ cell cancer	0.000157	0.00134	CbGeAlD
Valproic Acid—Pancytopenia—Methotrexate—germ cell cancer	0.000157	0.000942	CcSEcCtD
Valproic Acid—PTGS1—adrenal gland—germ cell cancer	0.000157	0.00134	CbGeAlD
Valproic Acid—Anaphylactic shock—Etoposide—germ cell cancer	0.000157	0.000942	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000156	0.000937	CcSEcCtD
Valproic Acid—Infection—Etoposide—germ cell cancer	0.000156	0.000936	CcSEcCtD
Valproic Acid—Asthenia—Dactinomycin—germ cell cancer	0.000155	0.000934	CcSEcCtD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000155	0.00265	CbGpPWpGaD
Valproic Acid—Dysuria—Methotrexate—germ cell cancer	0.000154	0.000928	CcSEcCtD
Valproic Acid—Neutropenia—Methotrexate—germ cell cancer	0.000154	0.000928	CcSEcCtD
Valproic Acid—Paraesthesia—Cisplatin—germ cell cancer	0.000153	0.000923	CcSEcCtD
Valproic Acid—Thrombocytopenia—Etoposide—germ cell cancer	0.000153	0.000923	CcSEcCtD
Valproic Acid—Tachycardia—Etoposide—germ cell cancer	0.000153	0.00092	CcSEcCtD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000152	0.00261	CbGpPWpGaD
Valproic Acid—Dyspnoea—Cisplatin—germ cell cancer	0.000152	0.000917	CcSEcCtD
Valproic Acid—SLC22A5—cerebellum—germ cell cancer	0.000152	0.00131	CbGeAlD
Valproic Acid—Skin disorder—Etoposide—germ cell cancer	0.000152	0.000915	CcSEcCtD
Valproic Acid—HDAC2—NOTCH1 Intracellular Domain Regulates Transcription—MYC—germ cell cancer	0.000152	0.0026	CbGpPWpGaD
Valproic Acid—Hyperhidrosis—Etoposide—germ cell cancer	0.000151	0.000911	CcSEcCtD
Valproic Acid—CYP3A5—endocrine gland—germ cell cancer	0.000151	0.0013	CbGeAlD
Valproic Acid—PTGS1—spinal cord—germ cell cancer	0.000151	0.00129	CbGeAlD
Valproic Acid—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000151	0.000906	CcSEcCtD
Valproic Acid—CYP2B6—endocrine gland—germ cell cancer	0.00015	0.00129	CbGeAlD
Valproic Acid—Anorexia—Etoposide—germ cell cancer	0.000149	0.000898	CcSEcCtD
Valproic Acid—CYP2C9—endocrine gland—germ cell cancer	0.000149	0.00127	CbGeAlD
Valproic Acid—Decreased appetite—Cisplatin—germ cell cancer	0.000149	0.000894	CcSEcCtD
Valproic Acid—CYP2B6—head—germ cell cancer	0.000148	0.00127	CbGeAlD
Valproic Acid—Diarrhoea—Dactinomycin—germ cell cancer	0.000148	0.000891	CcSEcCtD
Valproic Acid—Pneumonia—Methotrexate—germ cell cancer	0.000148	0.00089	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000148	0.000888	CcSEcCtD
Valproic Acid—Vomiting—Bleomycin—germ cell cancer	0.000147	0.000888	CcSEcCtD
Valproic Acid—Drowsiness—Methotrexate—germ cell cancer	0.000147	0.000885	CcSEcCtD
Valproic Acid—OGDH—Metabolism—CRABP1—germ cell cancer	0.000147	0.00252	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling by NOTCH—TP53—germ cell cancer	0.000147	0.00252	CbGpPWpGaD
Valproic Acid—Depression—Methotrexate—germ cell cancer	0.000147	0.000882	CcSEcCtD
Valproic Acid—Hypotension—Etoposide—germ cell cancer	0.000146	0.00088	CcSEcCtD
Valproic Acid—Rash—Bleomycin—germ cell cancer	0.000146	0.00088	CcSEcCtD
Valproic Acid—Pain—Cisplatin—germ cell cancer	0.000146	0.000879	CcSEcCtD
Valproic Acid—Dermatitis—Bleomycin—germ cell cancer	0.000146	0.000879	CcSEcCtD
Valproic Acid—Hypersensitivity—Ifosfamide—germ cell cancer	0.000146	0.000879	CcSEcCtD
Valproic Acid—PTGS1—female gonad—germ cell cancer	0.000146	0.00125	CbGeAlD
Valproic Acid—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000146	0.000877	CcSEcCtD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000144	0.00247	CbGpPWpGaD
Valproic Acid—Stomatitis—Methotrexate—germ cell cancer	0.000143	0.000863	CcSEcCtD
Valproic Acid—CYP2B6—testis—germ cell cancer	0.000143	0.00123	CbGeAlD
Valproic Acid—Conjunctivitis—Methotrexate—germ cell cancer	0.000143	0.00086	CcSEcCtD
Valproic Acid—HDAC9—Disease—SLC2A3—germ cell cancer	0.000143	0.00245	CbGpPWpGaD
Valproic Acid—Asthenia—Ifosfamide—germ cell cancer	0.000142	0.000856	CcSEcCtD
Valproic Acid—Sweating—Methotrexate—germ cell cancer	0.000141	0.000848	CcSEcCtD
Valproic Acid—Feeling abnormal—Cisplatin—germ cell cancer	0.000141	0.000848	CcSEcCtD
Valproic Acid—Paraesthesia—Etoposide—germ cell cancer	0.000141	0.000846	CcSEcCtD
Valproic Acid—Pruritus—Ifosfamide—germ cell cancer	0.00014	0.000844	CcSEcCtD
Valproic Acid—Dyspnoea—Etoposide—germ cell cancer	0.00014	0.00084	CcSEcCtD
Valproic Acid—Somnolence—Etoposide—germ cell cancer	0.000139	0.000838	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000139	0.000837	CcSEcCtD
Valproic Acid—Epistaxis—Methotrexate—germ cell cancer	0.000139	0.000835	CcSEcCtD
Valproic Acid—Nausea—Bleomycin—germ cell cancer	0.000138	0.000829	CcSEcCtD
Valproic Acid—Vomiting—Dactinomycin—germ cell cancer	0.000138	0.000828	CcSEcCtD
Valproic Acid—Agranulocytosis—Methotrexate—germ cell cancer	0.000137	0.000826	CcSEcCtD
Valproic Acid—Rash—Dactinomycin—germ cell cancer	0.000136	0.000821	CcSEcCtD
Valproic Acid—Decreased appetite—Etoposide—germ cell cancer	0.000136	0.000819	CcSEcCtD
Valproic Acid—SLC16A1—Hemostasis—CD9—germ cell cancer	0.000136	0.00233	CbGpPWpGaD
Valproic Acid—PTGS1—endocrine gland—germ cell cancer	0.000136	0.00116	CbGeAlD
Valproic Acid—Diarrhoea—Ifosfamide—germ cell cancer	0.000136	0.000816	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000135	0.000813	CcSEcCtD
Valproic Acid—Body temperature increased—Cisplatin—germ cell cancer	0.000135	0.000813	CcSEcCtD
Valproic Acid—Fatigue—Etoposide—germ cell cancer	0.000135	0.000812	CcSEcCtD
Valproic Acid—PTGS1—head—germ cell cancer	0.000134	0.00115	CbGeAlD
Valproic Acid—Constipation—Etoposide—germ cell cancer	0.000134	0.000806	CcSEcCtD
Valproic Acid—Pain—Etoposide—germ cell cancer	0.000134	0.000806	CcSEcCtD
Valproic Acid—Haemoglobin—Methotrexate—germ cell cancer	0.000133	0.000798	CcSEcCtD
Valproic Acid—Haemorrhage—Methotrexate—germ cell cancer	0.000132	0.000794	CcSEcCtD
Valproic Acid—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—MYC—germ cell cancer	0.000132	0.00226	CbGpPWpGaD
Valproic Acid—Dizziness—Ifosfamide—germ cell cancer	0.000131	0.000789	CcSEcCtD
Valproic Acid—Pharyngitis—Methotrexate—germ cell cancer	0.000131	0.000788	CcSEcCtD
Valproic Acid—Urinary tract disorder—Methotrexate—germ cell cancer	0.00013	0.000784	CcSEcCtD
Valproic Acid—PTGS1—testis—germ cell cancer	0.000129	0.00111	CbGeAlD
Valproic Acid—Urethral disorder—Methotrexate—germ cell cancer	0.000129	0.000779	CcSEcCtD
Valproic Acid—HDAC2—Chromatin modifying enzymes—H2AFZ—germ cell cancer	0.000129	0.00222	CbGpPWpGaD
Valproic Acid—Feeling abnormal—Etoposide—germ cell cancer	0.000129	0.000776	CcSEcCtD
Valproic Acid—Nausea—Dactinomycin—germ cell cancer	0.000128	0.000773	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Etoposide—germ cell cancer	0.000128	0.00077	CcSEcCtD
Valproic Acid—Visual impairment—Methotrexate—germ cell cancer	0.000127	0.000766	CcSEcCtD
Valproic Acid—Vomiting—Ifosfamide—germ cell cancer	0.000126	0.000758	CcSEcCtD
Valproic Acid—Hypersensitivity—Cisplatin—germ cell cancer	0.000126	0.000758	CcSEcCtD
Valproic Acid—Rash—Ifosfamide—germ cell cancer	0.000125	0.000752	CcSEcCtD
Valproic Acid—Dermatitis—Ifosfamide—germ cell cancer	0.000125	0.000751	CcSEcCtD
Valproic Acid—Erythema multiforme—Methotrexate—germ cell cancer	0.000125	0.000751	CcSEcCtD
Valproic Acid—Urticaria—Etoposide—germ cell cancer	0.000124	0.000748	CcSEcCtD
Valproic Acid—HDAC2—Hemostasis—CD9—germ cell cancer	0.000124	0.00213	CbGpPWpGaD
Valproic Acid—Body temperature increased—Etoposide—germ cell cancer	0.000124	0.000745	CcSEcCtD
Valproic Acid—Abdominal pain—Etoposide—germ cell cancer	0.000124	0.000745	CcSEcCtD
Valproic Acid—SLC22A5—brain—germ cell cancer	0.000124	0.00106	CbGeAlD
Valproic Acid—HDAC2—Circadian rythm related genes—AVP—germ cell cancer	0.000124	0.00212	CbGpPWpGaD
Valproic Acid—Eye disorder—Methotrexate—germ cell cancer	0.000123	0.000742	CcSEcCtD
Valproic Acid—HDAC2—Notch Signaling Pathway—MYC—germ cell cancer	0.000123	0.00211	CbGpPWpGaD
Valproic Acid—Tinnitus—Methotrexate—germ cell cancer	0.000123	0.000741	CcSEcCtD
Valproic Acid—HDAC2—Transcription—H2AFZ—germ cell cancer	0.000123	0.00211	CbGpPWpGaD
Valproic Acid—Asthenia—Cisplatin—germ cell cancer	0.000123	0.000738	CcSEcCtD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000121	0.00208	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00012	0.00206	CbGpPWpGaD
Valproic Acid—CYP2C8—brain—germ cell cancer	0.00012	0.00103	CbGeAlD
Valproic Acid—Angiopathy—Methotrexate—germ cell cancer	0.00012	0.000721	CcSEcCtD
Valproic Acid—SLC22A5—lymph node—germ cell cancer	0.00012	0.00102	CbGeAlD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000119	0.00205	CbGpPWpGaD
Valproic Acid—Immune system disorder—Methotrexate—germ cell cancer	0.000119	0.000718	CcSEcCtD
Valproic Acid—Mediastinal disorder—Methotrexate—germ cell cancer	0.000119	0.000716	CcSEcCtD
Valproic Acid—Chills—Methotrexate—germ cell cancer	0.000118	0.000713	CcSEcCtD
Valproic Acid—Nausea—Ifosfamide—germ cell cancer	0.000118	0.000709	CcSEcCtD
Valproic Acid—Diarrhoea—Cisplatin—germ cell cancer	0.000117	0.000704	CcSEcCtD
Valproic Acid—Alopecia—Methotrexate—germ cell cancer	0.000117	0.000702	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—FGF4—germ cell cancer	0.000116	0.00199	CbGpPWpGaD
Valproic Acid—Mental disorder—Methotrexate—germ cell cancer	0.000116	0.000696	CcSEcCtD
Valproic Acid—Hypersensitivity—Etoposide—germ cell cancer	0.000115	0.000694	CcSEcCtD
Valproic Acid—Malnutrition—Methotrexate—germ cell cancer	0.000115	0.000692	CcSEcCtD
Valproic Acid—CYP3A4—endocrine gland—germ cell cancer	0.000113	0.000972	CbGeAlD
Valproic Acid—UGT1A8—Metabolism—SLC2A3—germ cell cancer	0.000113	0.00194	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of Telomerase—MYC—germ cell cancer	0.000113	0.00194	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—NR0B1—germ cell cancer	0.000113	0.00194	CbGpPWpGaD
Valproic Acid—Dysgeusia—Methotrexate—germ cell cancer	0.000113	0.000677	CcSEcCtD
Valproic Acid—Asthenia—Etoposide—germ cell cancer	0.000112	0.000676	CcSEcCtD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000112	0.00192	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—SLC22A3—germ cell cancer	0.000111	0.00191	CbGpPWpGaD
Valproic Acid—Back pain—Methotrexate—germ cell cancer	0.000111	0.000669	CcSEcCtD
Valproic Acid—Pruritus—Etoposide—germ cell cancer	0.000111	0.000667	CcSEcCtD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00011	0.00189	CbGpPWpGaD
Valproic Acid—SLC16A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00011	0.00189	CbGpPWpGaD
Valproic Acid—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—MYC—germ cell cancer	0.000109	0.00187	CbGpPWpGaD
Valproic Acid—Vomiting—Cisplatin—germ cell cancer	0.000109	0.000654	CcSEcCtD
Valproic Acid—Vision blurred—Methotrexate—germ cell cancer	0.000108	0.000652	CcSEcCtD
Valproic Acid—Rash—Cisplatin—germ cell cancer	0.000108	0.000648	CcSEcCtD
Valproic Acid—Dermatitis—Cisplatin—germ cell cancer	0.000108	0.000648	CcSEcCtD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000108	0.00185	CbGpPWpGaD
Valproic Acid—CYP2B6—brain—germ cell cancer	0.000107	0.000921	CbGeAlD
Valproic Acid—Diarrhoea—Etoposide—germ cell cancer	0.000107	0.000645	CcSEcCtD
Valproic Acid—Ill-defined disorder—Methotrexate—germ cell cancer	0.000107	0.000642	CcSEcCtD
Valproic Acid—Anaemia—Methotrexate—germ cell cancer	0.000106	0.000639	CcSEcCtD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000104	0.00179	CbGpPWpGaD
Valproic Acid—Malaise—Methotrexate—germ cell cancer	0.000104	0.000624	CcSEcCtD
Valproic Acid—Dizziness—Etoposide—germ cell cancer	0.000104	0.000623	CcSEcCtD
Valproic Acid—Vertigo—Methotrexate—germ cell cancer	0.000103	0.000621	CcSEcCtD
Valproic Acid—Leukopenia—Methotrexate—germ cell cancer	0.000103	0.000619	CcSEcCtD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000103	0.00176	CbGpPWpGaD
Valproic Acid—SLC22A7—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000102	0.00175	CbGpPWpGaD
Valproic Acid—Nausea—Cisplatin—germ cell cancer	0.000101	0.000611	CcSEcCtD
Valproic Acid—Cough—Methotrexate—germ cell cancer	0.0001	0.000603	CcSEcCtD
Valproic Acid—Vomiting—Etoposide—germ cell cancer	9.95e-05	0.000599	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	9.91e-05	0.0017	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—SLC2A3—germ cell cancer	9.88e-05	0.00169	CbGpPWpGaD
Valproic Acid—Rash—Etoposide—germ cell cancer	9.87e-05	0.000594	CcSEcCtD
Valproic Acid—Dermatitis—Etoposide—germ cell cancer	9.86e-05	0.000594	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	9.82e-05	0.00168	CbGpPWpGaD
Valproic Acid—Headache—Etoposide—germ cell cancer	9.81e-05	0.00059	CcSEcCtD
Valproic Acid—Chest pain—Methotrexate—germ cell cancer	9.78e-05	0.000589	CcSEcCtD
Valproic Acid—Myalgia—Methotrexate—germ cell cancer	9.78e-05	0.000589	CcSEcCtD
Valproic Acid—Arthralgia—Methotrexate—germ cell cancer	9.78e-05	0.000589	CcSEcCtD
Valproic Acid—HDAC2—Gene Expression—DNMT3L—germ cell cancer	9.78e-05	0.00168	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—SLC22A3—germ cell cancer	9.73e-05	0.00167	CbGpPWpGaD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	9.71e-05	0.000585	CcSEcCtD
Valproic Acid—PTGS1—brain—germ cell cancer	9.71e-05	0.000833	CbGeAlD
Valproic Acid—Discomfort—Methotrexate—germ cell cancer	9.66e-05	0.000582	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—KITLG—germ cell cancer	9.53e-05	0.00164	CbGpPWpGaD
Valproic Acid—Confusional state—Methotrexate—germ cell cancer	9.45e-05	0.000569	CcSEcCtD
Valproic Acid—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	9.45e-05	0.00162	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.42e-05	0.00162	CbGpPWpGaD
Valproic Acid—PTGS1—lymph node—germ cell cancer	9.39e-05	0.000804	CbGeAlD
Valproic Acid—Anaphylactic shock—Methotrexate—germ cell cancer	9.38e-05	0.000564	CcSEcCtD
Valproic Acid—Infection—Methotrexate—germ cell cancer	9.32e-05	0.000561	CcSEcCtD
Valproic Acid—Nausea—Etoposide—germ cell cancer	9.3e-05	0.00056	CcSEcCtD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.28e-05	0.00159	CbGpPWpGaD
Valproic Acid—Nervous system disorder—Methotrexate—germ cell cancer	9.2e-05	0.000553	CcSEcCtD
Valproic Acid—Thrombocytopenia—Methotrexate—germ cell cancer	9.18e-05	0.000553	CcSEcCtD
Valproic Acid—Skin disorder—Methotrexate—germ cell cancer	9.11e-05	0.000548	CcSEcCtD
Valproic Acid—HDAC2—Gene Expression—RARS—germ cell cancer	9.09e-05	0.00156	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—CRABP1—germ cell cancer	9.07e-05	0.00156	CbGpPWpGaD
Valproic Acid—Hyperhidrosis—Methotrexate—germ cell cancer	9.06e-05	0.000546	CcSEcCtD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—TP53—germ cell cancer	8.98e-05	0.00154	CbGpPWpGaD
Valproic Acid—Anorexia—Methotrexate—germ cell cancer	8.94e-05	0.000538	CcSEcCtD
Valproic Acid—Hypotension—Methotrexate—germ cell cancer	8.76e-05	0.000527	CcSEcCtD
Valproic Acid—SLC22A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	8.55e-05	0.00147	CbGpPWpGaD
Valproic Acid—Musculoskeletal discomfort—Methotrexate—germ cell cancer	8.54e-05	0.000514	CcSEcCtD
Valproic Acid—Insomnia—Methotrexate—germ cell cancer	8.48e-05	0.00051	CcSEcCtD
Valproic Acid—Paraesthesia—Methotrexate—germ cell cancer	8.42e-05	0.000507	CcSEcCtD
Valproic Acid—Dyspnoea—Methotrexate—germ cell cancer	8.36e-05	0.000503	CcSEcCtD
Valproic Acid—Somnolence—Methotrexate—germ cell cancer	8.34e-05	0.000502	CcSEcCtD
Valproic Acid—Dyspepsia—Methotrexate—germ cell cancer	8.25e-05	0.000497	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—SLC2A3—germ cell cancer	8.24e-05	0.00141	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—HRAS—germ cell cancer	8.24e-05	0.00141	CbGpPWpGaD
Valproic Acid—HDAC2—Neural Crest Differentiation—MYC—germ cell cancer	8.23e-05	0.00141	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—FGF4—germ cell cancer	8.2e-05	0.00141	CbGpPWpGaD
Valproic Acid—Decreased appetite—Methotrexate—germ cell cancer	8.15e-05	0.000491	CcSEcCtD
Valproic Acid—ABAT—Transmission across Chemical Synapses—HRAS—germ cell cancer	8.15e-05	0.0014	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—SLC22A3—germ cell cancer	8.12e-05	0.00139	CbGpPWpGaD
Valproic Acid—Gastrointestinal disorder—Methotrexate—germ cell cancer	8.1e-05	0.000487	CcSEcCtD
Valproic Acid—Fatigue—Methotrexate—germ cell cancer	8.08e-05	0.000487	CcSEcCtD
Valproic Acid—Pain—Methotrexate—germ cell cancer	8.02e-05	0.000483	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	7.98e-05	0.00137	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CRABP1—germ cell cancer	7.93e-05	0.00136	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.86e-05	0.00135	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.74e-05	0.00133	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—MYC—germ cell cancer	7.74e-05	0.00133	CbGpPWpGaD
Valproic Acid—Feeling abnormal—Methotrexate—germ cell cancer	7.73e-05	0.000465	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methotrexate—germ cell cancer	7.67e-05	0.000461	CcSEcCtD
Valproic Acid—Urticaria—Methotrexate—germ cell cancer	7.45e-05	0.000448	CcSEcCtD
Valproic Acid—Body temperature increased—Methotrexate—germ cell cancer	7.41e-05	0.000446	CcSEcCtD
Valproic Acid—Abdominal pain—Methotrexate—germ cell cancer	7.41e-05	0.000446	CcSEcCtD
Valproic Acid—HDAC9—Disease—H2AFZ—germ cell cancer	7.33e-05	0.00126	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—germ cell cancer	7.18e-05	0.00123	CbGpPWpGaD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	7.13e-05	0.00122	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—FGFR3—germ cell cancer	7.08e-05	0.00122	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Methotrexate—germ cell cancer	6.91e-05	0.000416	CcSEcCtD
Valproic Acid—HDAC9—Disease—KITLG—germ cell cancer	6.74e-05	0.00116	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—OXT—germ cell cancer	6.73e-05	0.00116	CbGpPWpGaD
Valproic Acid—Asthenia—Methotrexate—germ cell cancer	6.73e-05	0.000405	CcSEcCtD
Valproic Acid—HDAC2—Cell Cycle—TP53—germ cell cancer	6.7e-05	0.00115	CbGpPWpGaD
Valproic Acid—Pruritus—Methotrexate—germ cell cancer	6.63e-05	0.000399	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—CRABP1—germ cell cancer	6.62e-05	0.00114	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.59e-05	0.00113	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—KIT—germ cell cancer	6.5e-05	0.00112	CbGpPWpGaD
Valproic Acid—Diarrhoea—Methotrexate—germ cell cancer	6.42e-05	0.000386	CcSEcCtD
Valproic Acid—UGT1A4—Metabolism—SLC2A3—germ cell cancer	6.36e-05	0.00109	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—germ cell cancer	6.36e-05	0.00109	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—SLC22A3—germ cell cancer	6.27e-05	0.00108	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—HRAS—germ cell cancer	6.24e-05	0.00107	CbGpPWpGaD
Valproic Acid—Dizziness—Methotrexate—germ cell cancer	6.2e-05	0.000373	CcSEcCtD
Valproic Acid—HDAC2—Disease—SLC2A3—germ cell cancer	6.19e-05	0.00106	CbGpPWpGaD
Valproic Acid—Vomiting—Methotrexate—germ cell cancer	5.96e-05	0.000359	CcSEcCtD
Valproic Acid—Rash—Methotrexate—germ cell cancer	5.91e-05	0.000356	CcSEcCtD
Valproic Acid—Dermatitis—Methotrexate—germ cell cancer	5.91e-05	0.000356	CcSEcCtD
Valproic Acid—Headache—Methotrexate—germ cell cancer	5.87e-05	0.000354	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—FGF4—germ cell cancer	5.75e-05	0.000986	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—SLC2A3—germ cell cancer	5.67e-05	0.000973	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—SLC22A3—germ cell cancer	5.59e-05	0.000959	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.58e-05	0.000959	CbGpPWpGaD
Valproic Acid—Nausea—Methotrexate—germ cell cancer	5.57e-05	0.000335	CcSEcCtD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.37e-05	0.000922	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—germ cell cancer	5.33e-05	0.000914	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—SLC2A3—germ cell cancer	5.29e-05	0.000908	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—SLC22A3—germ cell cancer	5.21e-05	0.000894	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—germ cell cancer	5.2e-05	0.000893	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—AVP—germ cell cancer	5.17e-05	0.000887	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—H2AFZ—germ cell cancer	5.13e-05	0.000881	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CRABP1—germ cell cancer	5.11e-05	0.000877	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—FGFR3—germ cell cancer	5.01e-05	0.00086	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	4.8e-05	0.000824	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KITLG—germ cell cancer	4.72e-05	0.00081	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—SLC2A3—germ cell cancer	4.62e-05	0.000794	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AVP—germ cell cancer	4.61e-05	0.000792	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—KIT—germ cell cancer	4.6e-05	0.000789	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CRABP1—germ cell cancer	4.55e-05	0.000782	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—SLC22A3—germ cell cancer	4.55e-05	0.000782	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—SLC2A3—germ cell cancer	4.5e-05	0.000772	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—SLC22A3—germ cell cancer	4.43e-05	0.00076	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—AVP—germ cell cancer	4.34e-05	0.000745	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CRABP1—germ cell cancer	4.25e-05	0.000729	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	3.98e-05	0.000684	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—germ cell cancer	3.9e-05	0.000669	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CRABP1—germ cell cancer	3.71e-05	0.000637	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—SLC2A3—germ cell cancer	3.65e-05	0.000627	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	3.62e-05	0.000622	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CRABP1—germ cell cancer	3.61e-05	0.00062	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—SLC22A3—germ cell cancer	3.6e-05	0.000618	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—FGF4—germ cell cancer	3.56e-05	0.000611	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—FGFR3—germ cell cancer	3.51e-05	0.000602	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.47e-05	0.000596	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—H2AFZ—germ cell cancer	3.42e-05	0.000587	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KIT—germ cell cancer	3.22e-05	0.000553	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—H2AFZ—germ cell cancer	3.18e-05	0.000545	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.13e-05	0.000537	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.1e-05	0.000532	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—SLC2A3—germ cell cancer	2.98e-05	0.000511	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CRABP1—germ cell cancer	2.93e-05	0.000504	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—SLC22A3—germ cell cancer	2.93e-05	0.000504	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KITLG—germ cell cancer	2.92e-05	0.000502	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—OXT—germ cell cancer	2.92e-05	0.000501	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.82e-05	0.000485	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SLC2A3—germ cell cancer	2.82e-05	0.000484	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—HRAS—germ cell cancer	2.81e-05	0.000482	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SLC22A3—germ cell cancer	2.78e-05	0.000476	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MYC—germ cell cancer	2.53e-05	0.000434	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FGF4—germ cell cancer	2.49e-05	0.000428	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.41e-05	0.000414	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CRABP1—germ cell cancer	2.39e-05	0.000411	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC2A3—germ cell cancer	2.27e-05	0.00039	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CRABP1—germ cell cancer	2.26e-05	0.000388	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC22A3—germ cell cancer	2.24e-05	0.000384	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—H2AFZ—germ cell cancer	2.22e-05	0.000382	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC2A3—germ cell cancer	2.22e-05	0.000381	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC22A3—germ cell cancer	2.19e-05	0.000376	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—FGFR3—germ cell cancer	2.17e-05	0.000373	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KITLG—germ cell cancer	2.05e-05	0.000351	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—germ cell cancer	2.04e-05	0.000349	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AVP—germ cell cancer	2e-05	0.000343	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KIT—germ cell cancer	1.99e-05	0.000342	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—germ cell cancer	1.99e-05	0.000341	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—germ cell cancer	1.95e-05	0.000334	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.92e-05	0.00033	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.9e-05	0.000325	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—germ cell cancer	1.86e-05	0.000319	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CRABP1—germ cell cancer	1.83e-05	0.000313	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CRABP1—germ cell cancer	1.78e-05	0.000306	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—germ cell cancer	1.78e-05	0.000306	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MYC—germ cell cancer	1.77e-05	0.000304	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC2A3—germ cell cancer	1.72e-05	0.000295	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC22A3—germ cell cancer	1.69e-05	0.00029	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC2A3—germ cell cancer	1.57e-05	0.000269	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CRABP1—germ cell cancer	1.55e-05	0.000265	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC22A3—germ cell cancer	1.54e-05	0.000265	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FGFR3—germ cell cancer	1.52e-05	0.000261	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—germ cell cancer	1.46e-05	0.00025	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KIT—germ cell cancer	1.4e-05	0.00024	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—germ cell cancer	1.39e-05	0.000239	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CRABP1—germ cell cancer	1.38e-05	0.000237	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.34e-05	0.00023	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.32e-05	0.000226	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CRABP1—germ cell cancer	1.26e-05	0.000216	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—germ cell cancer	1.18e-05	0.000203	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—germ cell cancer	1.1e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CRABP1—germ cell cancer	1.07e-05	0.000184	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.03e-05	0.000177	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.02e-05	0.000175	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—germ cell cancer	8.62e-06	0.000148	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CRABP1—germ cell cancer	8.29e-06	0.000142	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—germ cell cancer	7.68e-06	0.000132	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—germ cell cancer	6.31e-06	0.000108	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—germ cell cancer	6.04e-06	0.000104	CbGpPWpGaD
